Predictive model using systemic inflammation markers to assess neoadjuvant chemotherapy efficacy in breast cancer

Predictive model using systemic inflammation markers to assess neoadjuvant chemotherapy efficacy in breast cancer

BackgroundPathological complete response (pCR) is an important indicator for evaluating the efficacy of neoadjuvant chemotherapy (NAC) in breast cancer. The role of systemic inflammation markers in predicting pCR and the long-term prognosis of breast cancer patients undergoing NAC remains controvers...

Full description

Saved in:
Bibliographic Details
Main Authors: Yulu Sun, Yinan Guan, Hao Yu, Yin Zhang, Jinqiu Tao, Weijie Zhang, Yongzhong Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Oncology
Subjects:
breast cancer
systemic inflammation markers
pCR
prognosis
predictive model
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1552802/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items